+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Veterinary Infectious Disease Diagnostics Market, by Product Type and Application: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 5031430
  • Report
  • March 2020
  • Region: Global
  • 206 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Biomérieux SA
  • HESKA Corporation
  • ID.Vet
  • IDEXX Laboratories Inc.
  • Neogen Corporation
  • Qiagen N.V.
The global veterinary infectious disease diagnostics market was valued at $1,271 million in 2018, and is expected to reach $2,404 million by 2026, registering a CAGR of 8.3% from 2019 to 2026.



There are various types of infectious diseases, which affect companion animals. Furthermore, these diseases are fatal and can also lead to serious complications, if timely treatment is not provided. For instance, canine distemper is a common viral disease in dogs, which if left untreated lead to complications such as degeneration of the nervous system. Moreover, there are bacterial, parasitic and other type of infectious diseases as well that affect companion animals. The products used in procedures conducted to test the presence of infectious diseases in animals are known as veterinary infectious disease diagnostics. Moreover, there are different types of veterinary infectious disease diagnostics available in the market such as immunodiagnostics and molecular diagnostics. These are generally used to diagnose infectious diseases in animals such as cats and dogs.

Rise in ownership of companion animals and surge in animal health expenditure are the major factors that boost the veterinary infectious disease diagnostics growth of the global veterinary infectious disease diagnostics market. In addition, increase in The prevalence of various infectious diseases among companion animals significantly drives the growth of the veterinary infectious disease diagnostics market. However, lack of awareness related to the use of veterinary infectious disease diagnostics in underdeveloped countries restricts the growth of the market. On the contrary, surge in awareness related to animal healthcare across the globe is expected to offer remunerative opportunities for market expansion during the forecast period.

The global veterinary infectious disease diagnostics market size is studied on the basis of product type, application, and region. On the basis of product type, it is segmented into immunodiagnostics, molecular diagnostics, and others. By application, it is classified into dogs, cats, and others. By region, it is analyzed across North America (the U.S, Canada, and Mexico) and Europe (Germany, France, Italy, the UK and rest of Europe), Asia-Pacific (Japan, China, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
  • This report entails a detailed quantitative analysis along with the current global veterinary infectious disease diagnostics market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
  • The market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments

By Product Type
  • Immunodiagnostics
  • Molecular Diagnostics
  • Others

By Application
  • Dog
  • Cat
  • Others

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

List of key players profiled in the report:
  • Biomérieux SA
  • HESKA Corporation
  • IDEXX Laboratories, Inc.
  • ID.Vet, Neogen Corporation
  • Qiagen N.V.
  • Randox Laboratories Ltd
  • Thermo Fisher Scientific Inc
  • Virbac,
  • Zoetis

LIST OF OTHER PLAYERS IN THE VALUE CHAIN(These players are not profiled in the report. The same will be included on request)
  • Eurofins Technologies
  • AusDiagnostics Pty, Ltd.
Frequently Asked Questions about the Global Veterinary Infectious Disease Diagnostics Market

What is the estimated value of the Global Veterinary Infectious Disease Diagnostics Market?

The Global Veterinary Infectious Disease Diagnostics Market was estimated to be valued at $1271.0 million in 2018.

What is the growth rate of the Global Veterinary Infectious Disease Diagnostics Market?

The growth rate of the Global Veterinary Infectious Disease Diagnostics Market is 8.3%, with an estimated value of $2404.0 million by 2026.

What is the forecasted size of the Global Veterinary Infectious Disease Diagnostics Market?

The Global Veterinary Infectious Disease Diagnostics Market is estimated to be worth $2404.0 million by 2026.

Who are the key companies in the Global Veterinary Infectious Disease Diagnostics Market?

Key companies in the Global Veterinary Infectious Disease Diagnostics Market include Biomérieux SA, HESKA Corporation, IDEXX Laboratories Inc., ID.Vet, Neogen Corporation, Qiagen N.V., Randox Laboratories Ltd, Thermo Fisher Scientific Inc and Zoetis.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biomérieux SA
  • HESKA Corporation
  • ID.Vet
  • IDEXX Laboratories Inc.
  • Neogen Corporation
  • Qiagen N.V.

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Top player positioning
3.2.1. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Thereat of new entrants
3.3.4. Threat of substitutes
3.3.5. Intensity of competitive rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Surge in ownership of companion animals
3.4.1.2. Rise in animal health expenditure
3.4.1.3. Increase in demand for pet insurance
3.4.2. Restraint
3.4.2.1. Lack of veterinary infrastructure facilities in underdeveloped nations
3.4.3. Opportunity
3.4.3.1. Surge in awareness related to animal healthcare
3.4.4. Impact Analysis
CHAPTER 4: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Immunodiagnostics
4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Molecular Diagnostics
4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Others
4.4.1. Key market trends and growth opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Dogs
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Cats
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Others
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
CHAPTER 6: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. Market analysis, by country
6.2.2.1. U. S.
6.2.2.1.1. U. S. market size and forecast, by product type
6.2.2.1.2. U. S. market size and forecast, by application
6.2.2.2. Canada
6.2.2.2.1. Canada market size and forecast, by product type
6.2.2.2.2. Canada market size and forecast, by application
6.2.2.3. Mexico
6.2.2.3.1. Mexico market size and forecast, by product type
6.2.2.3.2. Mexico market size and forecast, by application
6.2.3. North America market size and forecast, by product type
6.2.4. North America market size and forecast, by application
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Market analysis, by country
6.3.2.1. Germany
6.3.2.1.1. Germany market size and forecast, by product type
6.3.2.1.2. Germany market size and forecast, by application
6.3.2.2. France
6.3.2.2.1. France market size and forecast, by product type
6.3.2.2.2. France market size and forecast, by application
6.3.2.3. UK
6.3.2.3.1. UK market size and forecast, by product type
6.3.2.3.2. UK market size and forecast, by application
6.3.2.4. Italy
6.3.2.4.1. Italy market size and forecast, by product type
6.3.2.4.2. Italy market size and forecast, by application
6.3.2.5. Rest of Europe
6.3.2.5.1. Rest of Europe market size and forecast, by product type
6.3.2.5.2. Rest of Europe market size and forecast, by application
6.3.3. Europe market size and forecast, by product type
6.3.4. Europe market size and forecast, by application
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Market analysis, by country
6.4.2.1. Japan
6.4.2.1.1. Japan market size and forecast, by product type
6.4.2.1.2. Japan market size and forecast, by application
6.4.2.3. China
6.4.2.3.1. China market size and forecast, by product type
6.4.2.3.2. China market size and forecast, by application
6.4.2.4. India
6.4.2.4.1. India market size and forecast, by product type
6.4.2.4.2. India market size and forecast, by application
6.4.2.5. Rest of Asia-Pacific
6.4.2.5.1. Rest of Asia-Pacific market size and forecast, by product type
6.4.2.5.2. Rest of Asia-Pacific market size and forecast, by application
6.4.3. Asia-Pacific market size and forecast, by product type
6.4.4. Asia-Pacific market size and forecast, by application
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. Market analysis, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil market size and forecast, by product type
6.5.2.1.2. Brazil market size and forecast, by application
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia market size and forecast, by product type
6.5.2.2.2. Saudi Arabia market size and forecast, by application
6.5.2.3. South Africa
6.5.2.3.1. South Africa market size and forecast, by product type
6.5.2.3.2. South Africa market size and forecast, by application
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA market size and forecast, by product type
6.5.2.4.2. Rest of LAMEA market size and forecast, by application
6.5.3. LAMEA market size and forecast, by product type
6.5.4. LAMEA market size and forecast, by application
CHAPTER 7: COMPANY PROFILES
7.1. bioMérieux SA
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. Heska Corporation
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. IDEXX Laboratories, Inc.
7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Product portfolio
7.3.1. Business performance
7.4. ID. Vet
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. Neogen Corporation
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. QIAGEN N. V.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. Randox Laboratories Ltd
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Key strategic moves and developments
7.8. THERMO FISHER SCIENTIFIC INC
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. Virbac.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. Zoetis
7.10.1. Company overview
7.10.2. Operating business segments
7.10.3. Product portfolio
7.10.4. Business performance
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biomérieux SA
  • HESKA Corporation
  • ID.Vet
  • IDEXX Laboratories Inc.
  • Neogen Corporation
  • Qiagen N.V.
According to this report titled, 'Veterinary infectious disease diagnostics Marketby Product Type, Application: Global Opportunity Analysis and Industry Forecast, 2018-2026,' the global veterinary infectious disease diagnostics market was valued at $1 billion in 2018, and is expected to reach $2 billion by 2026, registering a CAGR of 8.3% from 2019 to 2026.

Infectious diseases in animals are caused by different organisms such as bacteria, viruses, and. These infections lead to serious deterioration of animal health, which can also cause death. For instance, some serious infections caused by viruses in dogs include canine distemper and infectious canine hepatitis. Similarly, some infectious diseases caused by parasites in dogs include giardiasis and coccidiosis. Various tests and procedures are carried out to detect the presence of these viruses and bacteria in animal, which include use of products called veterinary infectious disease diagnostics. In addition, these diagnostics are used to perform tests on animals such as dogs, cats, and guinea pigs.

Rise in ownership of companion animals and surge in animal health expenditure are the major factors that boost the growth of the global veterinary infectious disease diagnostics market. In addition, increase in The prevalence of various infectious diseases among companion animals significantly drives the growth of the market. However, lack of awareness related to the use of veterinary infectious disease diagnostics in underdeveloped countries restricts the growth of the market. On the contrary, surge in awareness related to animal healthcare across the globe is expected to offer remunerative opportunities for market expansion during the forecast period.

The global veterinary infectious disease diagnostics market is segmented on the basis of product type, application, and region. On the basis of product type, it is segmented into immunodiagnostics, molecular diagnostics, and others. By application, it is classified into dogs, cats, and others. By region, it is analyzed across North America (the U.S, Canada, and Mexico) and Europe (Germany, France, Italy, the UK and rest of Europe), Asia-Pacific (Japan, China, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

By product type, the immunodiagnostics segment acquired the largest share of the veterinary infectious disease diagnostics market in 2018. Furthermore, the segment is expected to grow at the fastest rate during the forecast period due to factors such as surge in the The prevalence of infectious diseases in animals. Furthermore, other factor that contribute to the growth of the market include rise in animal healthcare expenditure. In addition, benefits associated with the use of these tests is another factor that fuels the growth of the market. For instance, lateral flow assays provide rapid results and sensitive & accurate diagnosis, which makes them a preferred choice. In addition, other benefits include low sample volume, low cost, and user-friendly operation. Therefore, aforementioned factors contribute to the growth of veterinary infectious disease diagnostics market.

By application, the dogs segment acquired the major share of the global veterinary infectious disease diagnostics market and is expected to exhibit the fastest growth rate during the forecast period, owing to surge in ownership of dogs as companion animals worldwide. Furthermore, surge in awareness related to dog health among their owners is another major factor that augments the growth of this segment.

On the basis of region, North America acquired a major share, owing to easy availability of veterinary infectious disease diagnostic products in the region, surge in pet ownership, and an increase in animal healthcare expenditure. However, Europe is expected to grow at the highest rate during the forecast period, due to surge in awareness related to animal health among owners. In addition, presence of majority of key players in Europe boosts the growth of the veterinary infectious disease diagnostics market in this region. .

According to Onkar Sumant, Manager, Healthcare, “The demand of veterinary infectious disease diagnostics is on a rise owing to surge in adoption of companion animals across the globe. Furthermore, rise in animal healthcare expenditure is another major factor that fuels the growth of the market.”

KEY FINDINGS OF THE STUDY
  • By product type, the immunodiagnostics segment accounted for a share of approximately half the share of veterinary infectious disease diagnostics market in 2018.
  • Region wise, Asia-Pacific is anticipated to grow at the highest CAGR throughout the forecast period.
  • Immunodiagnostics segment is anticipated to grow at the highest CAGR throughout the forecast period.
  • By application, dog segment accounted for a share of approximately half the share of veterinary infectious disease diagnostics market in 2018
Note: Product cover images may vary from those shown
  • Biomérieux SA
  • HESKA Corporation
  • IDEXX Laboratories Inc.
  • ID.Vet
  • Neogen Corporation
  • Qiagen N.V.
  • Randox Laboratories Ltd
  • Thermo Fisher Scientific Inc
  • Virbac
  • Zoetis
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...